Currently out of the existing stock ratings of Ann Hynes, 462 are a BUY (63.37%), 267 are a HOLD (36.63%).

Ann Hynes

Work Performance Price Targets & Ratings Chart

Analyst Ann Hynes, currently employed at MIZUHO, carries an average stock price target met ratio of 69.63% that have a potential upside of 14.99% achieved within 251 days.

Ann Hynes’s has documented 1,440 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Communication Services, Financial Services, Consumer Cyclical sectors.

Most recent stock forecast was given on IQV, IQVIA Holdings at 07-Oct-2026.

Wall Street Analyst Ann Hynes

Analyst best performing recommendations are on PRAH (PRA HEALTH SCIENCES).
The best stock recommendation documented was for WBA (WALGREENS BOOTS ALLIANCE) at 10/14/2024. The price target of $10 was fulfilled within 1 day with a profit of $1.27 (14.55%) receiving and performance score of 145.48.

Average potential price target upside

of $75.98 (22.82%) on UNH (UNITEDHEALTH GROUP).
of $57.49 (18.39%) on HUM (HUMANA).
of $55.86 (16.72%) on ELV (ELEVANCE HEALTH).

ACHC Acadia Healthcare Company ANTM Anthem CAH Cardinal Health CI Cigna Corp CNC Centene Corp CVS CVS Health Corp DGX Quest Diagnostics EHC Encompass Health Corp HCA HCA Holdings HUM Humana ICLR ICON PLC IQV IQVIA Holdings LH Laboratory of America Holdings MCK McKesson MD Mednax MOH Molina Healthcare PRAH PRA Health Sciences THC Tenet Healthcare UHS Universal Health Services WBA Walgreens Boots Alliance ABC AmerisourceBergen DPLO Diplomat Pharmacy EVHC Envision Healthcare Holdings PPD PPD RAD Rite Aid SYNH Syneos Health UNH UnitedHealth Group ELV Elevance Health SGRY Surgery Partners IQ iQIYI CRL Charles River Laboratories BTSG BrightSpring Health Services FTRE Fortrea Holdings MEDP Medpace Holdings Q Quintiles Transnational ACAD ACADIA Pharmaceuticals AB AllianceBernstein Holding L.P. AN AutoNation ARDT Ardent Health Partners CYH Community Health Systems PRA ProAssurance SEM Select Medical Holdings SY So-Young International WB Weibo Corp COR Cencora

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Whit Mayo (LEERINK)

Hold Since 23-Sep-2026

$33

$3.02 (10.07%)

28 days ago
(23-Sep-2026)

8/14 (57.14%)

$4.49 (15.75%)

404

Please subscribe to see extended stock data

Andrew Mok (BARCLAYS)

Hold Since 14-May-2025

$32

$2.02 (6.74%)

$25

2 months 21 days ago
(30-Jul-2026)

8/20 (40%)

$3.86 (13.72%)

127

Please subscribe to see extended stock data

Jason Cassorla (GUGGENHEIM)

Buy Since 09-Apr-2025

$39

$9.02 (30.09%)

$38

2 months 21 days ago
(30-Jul-2026)

4/7 (57.14%)

$10.86 (38.59%)

135

Please subscribe to see extended stock data

Ryan Langston (TD COWEN)

Buy Since 07-Jan-2025

$36

$6.02 (20.08%)

$30

3 months 7 days ago
(14-Jul-2026)

4/8 (50%)

$4.4 (13.92%)

Please subscribe to see extended stock data

Matthew Gillmor (KEYBANK)

Buy Since 05-Feb-2025

$40

$10.02 (33.42%)

$30

3 months 7 days ago
(14-Jul-2026)

7/12 (58.33%)

$8.4 (26.58%)

186

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Ann Hynes most bullish on?

Potential upside of $81.53 has been obtained for MEDP (MEDPACE HOLDINGS)

Which stock is Ann Hynes most reserved on?

Potential downside of -$23.16 has been obtained for HUM (HUMANA)

What Year was the first public recommendation made by Ann Hynes?

On 2011